Novel insights into disease modeling using induced pluripotent stem cells

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Induced pluripotent stem cell (iPSC) technology has great potential to establish novel therapeutic approaches in regenerative medicine and disease analysis. Although cell therapy using iPSC-derived cells still has many hurdles to overcome before clinical applications, disease analysis using patient-specific iPSCs may be of practical use in the near future. There are several reports that patient-specific iPSC-derived cells have recapitulated the apparent cellular phenotypes of a wide variety of diseases. Moreover, some studies revealed that it could be possible to discover effective new drugs and to clarify disease pathogenesis by examination of patient-specific iPSC-derived cells in vitro. We have recently reported that iPSCs can be a diagnostic tool in a patient with a novel mutation. For definitive diagnosis in a patient with long QT syndrome who had an uncharacterized genetic mutation, we succeeded in clarifying the patient's cellular electrophysiologic characteristics and the molecular mechanism underlying the disease phenotype through the multifaceted analyses of patient-specific iPSC-derived cardiomyocytes. In this review, we focus on the conceptual and practical issues in disease modeling using patient-specific iPSCs and discuss future directions in this research field.

Original languageEnglish
Pages (from-to)182-188
Number of pages7
JournalBiological and Pharmaceutical Bulletin
Volume36
Issue number2
DOIs
Publication statusPublished - 2013 Feb

Fingerprint

Induced Pluripotent Stem Cells
Phenotype
Long QT Syndrome
Mutation
Regenerative Medicine
Cell- and Tissue-Based Therapy
Cardiac Myocytes
Technology
Research
Pharmaceutical Preparations

Keywords

  • Cardiovascular disease
  • Disease modeling
  • Induced pluripotent stem cell
  • Long QT syndrome

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

Novel insights into disease modeling using induced pluripotent stem cells. / Egashira, Toru; Yuasa, Shinsuke; Fukuda, Keiichi.

In: Biological and Pharmaceutical Bulletin, Vol. 36, No. 2, 02.2013, p. 182-188.

Research output: Contribution to journalArticle

@article{ef11fd1834e449fab2911320de12c2e1,
title = "Novel insights into disease modeling using induced pluripotent stem cells",
abstract = "Induced pluripotent stem cell (iPSC) technology has great potential to establish novel therapeutic approaches in regenerative medicine and disease analysis. Although cell therapy using iPSC-derived cells still has many hurdles to overcome before clinical applications, disease analysis using patient-specific iPSCs may be of practical use in the near future. There are several reports that patient-specific iPSC-derived cells have recapitulated the apparent cellular phenotypes of a wide variety of diseases. Moreover, some studies revealed that it could be possible to discover effective new drugs and to clarify disease pathogenesis by examination of patient-specific iPSC-derived cells in vitro. We have recently reported that iPSCs can be a diagnostic tool in a patient with a novel mutation. For definitive diagnosis in a patient with long QT syndrome who had an uncharacterized genetic mutation, we succeeded in clarifying the patient's cellular electrophysiologic characteristics and the molecular mechanism underlying the disease phenotype through the multifaceted analyses of patient-specific iPSC-derived cardiomyocytes. In this review, we focus on the conceptual and practical issues in disease modeling using patient-specific iPSCs and discuss future directions in this research field.",
keywords = "Cardiovascular disease, Disease modeling, Induced pluripotent stem cell, Long QT syndrome",
author = "Toru Egashira and Shinsuke Yuasa and Keiichi Fukuda",
year = "2013",
month = "2",
doi = "10.1248/bpb.b12-00960",
language = "English",
volume = "36",
pages = "182--188",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "2",

}

TY - JOUR

T1 - Novel insights into disease modeling using induced pluripotent stem cells

AU - Egashira, Toru

AU - Yuasa, Shinsuke

AU - Fukuda, Keiichi

PY - 2013/2

Y1 - 2013/2

N2 - Induced pluripotent stem cell (iPSC) technology has great potential to establish novel therapeutic approaches in regenerative medicine and disease analysis. Although cell therapy using iPSC-derived cells still has many hurdles to overcome before clinical applications, disease analysis using patient-specific iPSCs may be of practical use in the near future. There are several reports that patient-specific iPSC-derived cells have recapitulated the apparent cellular phenotypes of a wide variety of diseases. Moreover, some studies revealed that it could be possible to discover effective new drugs and to clarify disease pathogenesis by examination of patient-specific iPSC-derived cells in vitro. We have recently reported that iPSCs can be a diagnostic tool in a patient with a novel mutation. For definitive diagnosis in a patient with long QT syndrome who had an uncharacterized genetic mutation, we succeeded in clarifying the patient's cellular electrophysiologic characteristics and the molecular mechanism underlying the disease phenotype through the multifaceted analyses of patient-specific iPSC-derived cardiomyocytes. In this review, we focus on the conceptual and practical issues in disease modeling using patient-specific iPSCs and discuss future directions in this research field.

AB - Induced pluripotent stem cell (iPSC) technology has great potential to establish novel therapeutic approaches in regenerative medicine and disease analysis. Although cell therapy using iPSC-derived cells still has many hurdles to overcome before clinical applications, disease analysis using patient-specific iPSCs may be of practical use in the near future. There are several reports that patient-specific iPSC-derived cells have recapitulated the apparent cellular phenotypes of a wide variety of diseases. Moreover, some studies revealed that it could be possible to discover effective new drugs and to clarify disease pathogenesis by examination of patient-specific iPSC-derived cells in vitro. We have recently reported that iPSCs can be a diagnostic tool in a patient with a novel mutation. For definitive diagnosis in a patient with long QT syndrome who had an uncharacterized genetic mutation, we succeeded in clarifying the patient's cellular electrophysiologic characteristics and the molecular mechanism underlying the disease phenotype through the multifaceted analyses of patient-specific iPSC-derived cardiomyocytes. In this review, we focus on the conceptual and practical issues in disease modeling using patient-specific iPSCs and discuss future directions in this research field.

KW - Cardiovascular disease

KW - Disease modeling

KW - Induced pluripotent stem cell

KW - Long QT syndrome

UR - http://www.scopus.com/inward/record.url?scp=84874023197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874023197&partnerID=8YFLogxK

U2 - 10.1248/bpb.b12-00960

DO - 10.1248/bpb.b12-00960

M3 - Article

C2 - 23370349

AN - SCOPUS:84874023197

VL - 36

SP - 182

EP - 188

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 2

ER -